Browse by Vaccine Type

This page shows data for Live-attenuated vaccine type.
Total Entries Retrieved: 64
IDVaccine NameDisease NameDisease ClassificationVirus NameNucleic Acid ContentVaccine TypeVaccine StatusManufacturerYear of ManufacturingManufacturing CountryAgeDosageAdministration RouteAdjuvantTarget StrainDescriptionApproving OrganisationCollaborating OrganisationOther CountriesTrade NamePMIDClinical Trial IDReference LinkAdditional Links
10008 PiCoVacc COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Approved Sinovac Biotech Ltd. 2020 China 18 - 59 years 2 doses 14 or 28 days apart Intramuscular Aluminum (alum) NA NA WHO NA Brazil, Indonesia, Turkey CoronaVac 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202686/
10009 Sinopharm Vaccine (Vero cell inactivated) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Approved Sinopharm 2020 China NA 2 doses 14 or 21 days apart Intramuscular Aluminum (alum) NA NA WHO NA Jordan, Bahrain, Morocco, UAE NA 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://covid19.health.gov.mv/wp-content/uploads/2021/10/SINOPHARM-INFORMATION-SHEET_Final-Revised-09th-June.pdf
10010 BBIBP-CorV (Vero cell) (Covilo) COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Approved China National Biotec Group Company Limited 2021 China 18 years and above 2 doses 14 or 28 days apart Intramuscular Aluminum NA NA WHO Beijing Institute of Biotechnology UAE, Jordan, Egypt, Bahrain, Argentina BBIBP-CorV, COVILO 32328406 NA https://pubmed.ncbi.nlm.nih.gov/32328406/ https://www.precisionvaccinations.com/vaccines/sinopharm-covid-19-vaccine-bbibp-corv
10081 Flublok Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2013 NA 18 years and above Single dose Intramuscular NA Hemagglutinin NA US FDA NA NA NA NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10082 FluMist Quadrivalent Influenza (flu) Respiratory Influenza virus positive-sense, single-stranded RNA Live-attenuated Approved AstraZeneca plc 2003 Canada 2 - 49 years Single dose Intranasal NA Hemagglutinin Egg based US FDA NA NA Tamiflu, Relenza NA NA https://www.cdc.gov/flu/prevent/flushot.htm https://www.cdc.gov/flu/professionals/acip/2021-2022/acip-table.htm
10084 ERVEBO Ebola Hemorrhagic Zaire ebolavirus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. 2019 USA 18 years and above Single dose Intramuscular NA Zaire Ebola virus glycoprotein NA US FDA, EMA NA NA V920, rVSV-G-ZEBOV-GP, rVSV-ZEBOV NA NA https://www.cdc.gov/vhf/ebola/clinicians/vaccine/index.html https://www.thelancet.com/journals/laninf/article/PIIS1473-3099%2817%2930313-4/fulltext
10086 YF-Vax Yellow fever Hemorrhagic Yellow fever virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur NA France 9 months and above Single dose Subcutaneous NA 17D-204 strain of yellow fever virus Culturing 17D-204 strain of yellow fever virus in living avian leukosis virus-free (ALV-free) chicken embryos US FDA NA NA NA NA NA https://www.fda.gov/media/76015/download https://www.fda.gov/media/76015/download
10087 CYD-TDV Dengvaxia Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2015 France 9 - 45 years 3 doses 6 months apart Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) 17D vaccine vector expressing genes of DENV-1, 2, 3, or 4 US FDA NA NA NA 30684747 NCT02747927 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://www.fda.gov/media/124379/download
10088 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Biogenetech Co. Ltd., Zhejiang Pukang Biotechnology Co. Ltd. 2010 Thailand 1.5 years and above Single dose Subcutaneous NA H2 strain of HAV H2-attenuated strain of HAV cultured in human diploid cells. China FDA, US FDA NA NA MEVAC-A 24280971 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/ https://apps.who.int/iris/bitstream/handle/10665/326501/97892516327-eng.pdf
10089 Weisairuiji Biovac-A Mevac-A Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Institute of Medical Biology, Chinese Academy of Medical Sciences NA China NA Single dose Subcutaneous NA H2 strain of HAV NA China FDA, US FDA NA NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.fda.moph.go.th/sites/drug/Shared%20Documents/Vaccine/U1DR1C1072530000811C-SPC.pdf
10090 HAVAC Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Changchun Institute of Biological Products NA China NA Single dose Subcutaneous NA LA-1 NA Government of Canada Changchun Changsheng Life Sciences NA NA 24280971 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130259/ https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
10091 HAVAC Hepatitis A Hepatitic Hepatitis A virus positive-sense, single-stranded RNA Live-attenuated Approved Changchun Institute of Biological Products NA China NA Single dose Subcutaneous NA LA-1 NA Government of Canada Changchun Changsheng Life Sciences NA NA 29661808 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ https://www.canada.ca/en/public-health/services/publications/healthy-living/update-recommended-use-hepatitis-b-vaccine.html
10121 KAMRAB-003 Rabies Neurologic Rabies virus negative-sense, single-stranded RNA Live-attenuated Approved Kamada Ltd. 2014 USA 18 - 75 years 5 doses on day 0, 3, 7, 14 and 28 Intramuscular NA NA NA US FDA NA NA NA NA NCT02040090 https://clinicaltrials.gov/ct2/show/NCT02040090?cond=Rabies+Human&phase=23&draw=2&rank=5 https://pdf.hres.ca/dpd_pm/00048173.PDF
10123 SA14-14-2 (IXIARO) Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2013 Thailand NA NA Subcutaneous NA SA 14-14-2 Cell culture based NA NA NA NA 24161909 NCT01092507 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ https://www.fda.gov/media/75777/download
10126 IMOJEV Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Live-attenuated Approved Sanofi Pasteur 2017 Thailand 9 months and above 3 doses Subcutaneous NA SA 14-14-2 Mouse brain based US FDA NA NA ChimeriVax-JE, JE-CV, THAIJEV (Sanofi-Aventis) 24161909 NCT01900444 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ https://www.fda.gov/vaccines-blood-biologics/vaccines/japanese-encephalitis-vaccine-inactivated-adsorbed
10131 ACAM2000 Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved Emergent BioSolutions 2003 USA Below 12 months of age Single dose Percutaneous NA Recombinant vaccinia viruses derived from replication-competent vaccinia strain Lyophilized US FDA NA NA NA NA NA https://www.fda.gov/vaccines-blood-biologics/vaccines/acam2000 NA
10132 JYNNEOS Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved Bavarian Nordic NA Denmark 18 years and above 2 doses 4 weeks apart Subcutaneous NA Vaccinia Virus Ankar NA US FDA NA NA Imvamune, Imvanex, MVA-BN NA NA https://www.fda.gov/vaccines-blood-biologics/jynneos https://www.fda.gov/media/131078/download
10133 Aventis Pasteur Smallpox Vaccine Smallpox Exanthous Variola virus double stranded DNA Live-attenuated Approved National Institute of Allergy and Infectious Diseases 2010 USA 18 - 32 years NA Percutaneous NA NA NA US FDA NA NA NA NA NCT00038987 https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/smallpox-preparedness-and-response-updates-fda https://clinicaltrials.gov/ct2/show/NCT00038987
10134 Priorix Measles, Mumps, Rubella, Chickenpox Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Approved GlaxoSmithKline 2019 NA 11 months - 22 months 2 doses 42 days apart Subcutaneous NA Vaccinia Virus NA NA NA NA NA NA NCT00226499 https://www.fda.gov/vaccines-blood-biologics/priorix https://clinicaltrials.gov/ct2/show/NCT00226499
10135 Varivax Chickenpox Exanthous Varicella-zoster virus double stranded DNA Live-attenuated Approved Merck & Co. Inc. 2007 USA 1 - 12 years 2 doses (0.5 ml each) separated by at least 3 months.# First dose: age 12 through 15 months, Second dose: age 4 through 6 years Subcutaneous NA Oka/Merck strain of live-attenuated varicella virus NA US FDA NA NA NA NA NCT00822237 https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax
10136 Varivax Chickenpox Exanthous Varicella-zoster virus double stranded DNA Live-attenuated Approved Merck & Co. Inc. 2007 USA 12 - 23 months 2 doses 4 weeks apart Subcutaneous NA Oka/Merck strain of live-attenuated varicella virus NA US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax
10137 ProQuad Measles, Mumps, Rubella, Varicella Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Approved Merck & Co. Inc. NA USA 1 - 12 years First dose at 12 through 15 months of age and Second dose at 4 through 6 years of age Subcutaneous NA NA NA US FDA NA NA NA NA NCT00985166 https://www.cdc.gov/vaccines/vpd/varicella/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/proquad
10138 RotaTeq (RV5) Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved Merck & Co. Inc. NA USA 6 months - 8 months 3 doses at age of 2 months, 4 months, and 6 months Oral NA 5 human-bovine reassortant rotaviruses (G1, G2, G3 G4, P[8]) NA US FDA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rotavirus/index.html https://www.fda.gov/media/75718/download
10139 Rotarix (RV1) Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved GlaxoSmithKline 2006 UK 6 months - 8 months 2 doses at ages 2 months and 4 months Oral NA Human rotavirus strain (G1P[8]) NA US FDA, EMA NA NA NA NA NA https://www.cdc.gov/vaccines/vpd/rotavirus/index.html https://www.fda.gov/vaccines-blood-biologics/vaccines/rotarix
10140 Rotavac Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved Bharat Biotech International Limited 2013 India 6 months - 8 months 3 doses 4 weeks apart Oral NA Rotavirus 116E strain NA US FDA, Government of India NA NA NA NA NA https://www.who.int/immunization/research/meetings_workshops/11_Cassels_Rotavirus_PDVAC_2019.pdf?ua=1 https://www.fda.gov/vaccines-blood-biologics/vaccines/rotavirus-vaccine-live-oral
10141 RotaSiil Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Approved Serum Institute of India 2017 India 6 months - 8 months 3 doses 4 weeks apart Oral NA Human-bovine reassortant rotaviruses (G1, G2, G3, G4, G9) NA National Institute of Health, Government of India NA NA NA NA NA https://www.who.int/immunization/research/meetings_workshops/11_Cassels_Rotavirus_PDVAC_2019.pdf?ua=1 https://www.fda.gov/vaccines-blood-biologics/vaccines/rotarix
10142 BL 125296 Adenovirus Infection Respiratory Adenovirus Type 4, Type 7 double stranded DNA Live-attenuated Approved Barr Pharmaceuticals Inc. NA USA 17 - 50 years 2 doses Oral NA Live adenovirus NA US FDA NA NA NA NA NA https://www.fda.gov/media/80211/download https://www.fda.gov/vaccines-blood-biologics/vaccines/adenovirus-type-4-and-type-7-vaccine-live-oral
10162 COVI-VAC COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Phase 1 Codagenix Inc. 2021 UK 18 - 30 years 2 doses 28 days apart Intranasal NA SARS CoV 2 whole virus NA NA Serum Institute of India NA CDX-005 33816047 NCT04619628 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003899/ NA
10175 MV-014-212 COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Phase 1 Meissa Vaccines Inc. 2021 USA 18 - 69 years 2 doses 35 days apart Intranasal NA Spike protein of SARS-CoV-2 virus NA NA NA NA NA NA NCT04798001 https://clinicaltrials.gov/ct2/show/NCT04798001?term=covid-19+vaccine&draw=2 NA
10211 rDEN3delta30/31-7164 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 1 National Institute of Allergy and Infectious Diseases 2013 USA 18 - 50 years NA Subcutaneous NA Dengue virus serotypes -3 NA NA Johns Hopkins Bloomberg School of Public Health NA NA NA NCT00831012 https://clinicaltrials.gov/ct2/show/NCT00831012?recrs=abde&cond=dengue+fever&phase=0123&draw=2&rank=12 NA
10212 MV-LASV (V182-001) Lassa fever Hemorrhagic Lassa virus negative-sense, single-stranded RNA Live-attenuated Phase 1 Themis Bioscience 2021 Belgium 18 - 55 years 2 doses 28 days apart Intramuscular NA Measles Schwarz virus strain for prophylaxis of Lassa infection NA NA NA NA NA NA NCT04055454 https://clinicaltrials.gov/ct2/show/NCT04055454?cond=Lassa+fever&draw=2&rank=10 NA
10214 RH-CHIKV EV-CHIKV RHEV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA Single dose Footpad injection NA R532H-nsP, E515V-nsP2 NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10215 Delta 5nsP3 DREP-E MVA-CE Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA Single dose Subcutaneous NA CHIKV nsP3 envelope and capsid protein NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10223 USAMRIID Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA 1- 2 doses depending on volume and age NA NA NA Formalin inactivated produced in green monkey kidney cells or chick embryonic cells NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10225 Measles-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA Single dose NA NA CHIKV proteins Recombinant measles virus (Schwartz strain) expressing CHIKV VLPs NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10226 TSI-GSD-218 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10227 CHIKV Delta 5nsP3 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 NA NA NA NA NA NA NA Clinical strain attenuated by targeted mutations in nsP3, 6 K NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10233 IRES-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 1 University of Texas Medical Branch, Takeda Pharmaceutical Company Limited 2011 USA NA NA Subcutaneous NA La Reunion strain NA NA NA NA NA NA NA https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145802/
10298 CHIKV-NoLS Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 NA NA NA NA Single dose Subcutaneous NA N-terminal region of capsid protein NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10303 MV-CHIK Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 Themis Bioscience 2021 USA 21 - 65 years 2 doses 28 days apart Intramuscular NA NA NA US FDA Walter Reed Army Institute of Research NA NA NA NCT03807843 https://clinicaltrials.gov/ct2/show/NCT03807843 NA
10304 TSI-GSD-218 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 NA NA NA NA Single dose NA NA NA Attenuation by serial, plaque-to-plaque MRC5 cell passages NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10307 MV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Phase 2 Institut Pasteur of Shanghai, Themis Bioscience 2021 NA 18 - 55 years 3 doses on day 0, 28 and 196 Intramuscular NA NA NA NA NA NA NA NA NCT02861586 https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006919 https://clinicaltrials.gov/ct2/show/NCT02861586
10309 MeMuRu-OKA Measles, Mumps, Rubella, Varicella Exanthous Morbillivirus, Mumps virus, Rubella virus, Varicella-zoster virus negative-sense, single-stranded RNA Live-attenuated Phase 2 GlaxoSmithKline 2016 Canada 15 months - 6 years NA Subcutaneous NA Jeryl Lynn strain, Schwarz strain, RA 27/3 strain, OKA strain NA NA NA NA NA NA NCT00352898 https://clinicaltrials.gov/ct2/show/NCT00352898 https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-006065-14/DE
10312 RV3-BB Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Phase 2 PT Biofarma NA Indonesia 0 - 5 days 3 doses regimen child schedule (0 to 5 days, 8 weeks, and 14 weeks of age or an infant schedule (8 weeks, 14 weeks, and 18 weeks of age) Oral NA Three VP8 subunit proteins expressing P[4], P[6] and P[8] serotypes NA NA NA NA NA NA NA https://preventrotavirus.org/wp-content/uploads/2019/05/ROTA-Brief2-ProductLandscape-SP-1-3.pdf NA
10318 Covidful COVID-19 Respiratory SARS-CoV-2 virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Chinese Academy of Medical Sciences 2021 China 18 years and above 2 doses 2 weeks apart Intramuscular NA NA NA NA Institute of Medical Biology Brazil, Malaysia IMBCAMS COVID-19 vaccine NA NCT04659239 https://clinicaltrials.gov/show/NCT04659239 https://clinicaltrials.gov/ct2/show/NCT05164731
10359 RSV F vaccine Respiratory syncytial virus infection Respiratory Respiratory syncytial virus negative-sense, single-stranded RNA Live-attenuated Phase 3 Novavax Inc. 2020 USA 18 - 40 years 2 doses 9 months apart Intramuscular Aluminum RSV surface glycoprotein NA NA Bill and Melinda Gates Foundation NA NA NA NCT02624947 https://clinicaltrials.gov/ct2/show/NCT02624947?recrs=bde&cond=Respiratory+Syncytial+Virus+%28RSV%29&phase=23&draw=2&rank=2 NA
10363 STAMARiL Yellow fever Hemorrhagic Yellow fever virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Sanofi Pasteur NA France 10 months Single dose Subcutaneous NA 17D-204 strain of yellow fever virus Produced in specified pathogen-free chick embryos NA NA NA NA NA NA https://www.sanofipasteur.co.uk/-/media/ems/conditions/vaccines/brands/oneportal-ie/pdf/105_stamaril_mah_address_update_12_2017_uk.pdf NA
10364 TAK-003 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Takeda Pharmaceutical Company Limited NA USA 4 - 16 years NA Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) Mammalian cell vero culture NA NA NA TDV 30684747 NA https://www.sciencedirect.com/science/article/pii/S1201971219300402 NA
10365 TV-003/005 Dengue fever Hemorrhagic Dengue virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Merck & Co. Inc. NA Brazil 2 - 59 years NA Subcutaneous NA Dengue virus serotypes (1, 2, 3 and 4) Mammalian cell vero culture NA National Institute of Allergy and Infectious Diseases NA TetraVax-DV 30684747 NCT02406729 https://www.sciencedirect.com/science/article/pii/S1201971219300402 https://clinicaltrials.gov/ct2/show/NCT02406729
10370 JE-VAX Viral encephalitis Neurologic West Nile virus positive-sense, single-stranded RNA Live-attenuated Phase 3 Research Foundation for Microbial Diseases of Osaka University NA China NA NA Subcutaneous NA Nakayama-NIH/Beijing-1(P1) strain Mouse brain based NA NA Asia SA 14-14-2 vaccine 24161909 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4185882/ NA
10374 MRVAC Measles, Rubella Exanthous Morbillivirus, Rubella virus negative-sense, single-stranded RNA Live-attenuated Phase 3 Center for Research and Production of Vaccines and Biologicals 2018 Vietnam 1 - 45 years NA Subcutaneous NA Strain AIK-C measles virus clone with Takahashi rubella virus NA NA NA NA NA NA NCT03713359 https://clinicaltrials.gov/ct2/show/NCT03713359?recrs=abde&cond=measles+vaccines&phase=123&draw=2&rank=54 NA
10377 Lamb rotavirus Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Phase 4 Lanzhou Biologicals 2000 China 6 months - 35 months NA Oral NA Single strain of rotavirus found in lamb (G10P) NA NA NA NA NA NA NA https://www.who.int/immunization/research/meetings_workshops/11_Cassels_Rotavirus_PDVAC_2019.pdf?ua=1 https://preventrotavirus.org/wp-content/uploads/2019/05/ROTA-Brief2-ProductLandscape-SP-1-3.pdf
10378 ROTAVIN-M1 Rotavirus Infection Gastrointestinal Rotavirus double stranded RNA Live-attenuated Phase 4 Polyvac, Center for Research and Production of Vaccines NA Vietnam 6 months - 8 months NA Oral NA Human rotavirus strain (G1P) NA NA NA NA NA NA NA https://www.who.int/immunization/research/meetings_workshops/11_Cassels_Rotavirus_PDVAC_2019.pdf?ua=1 https://preventrotavirus.org/wp-content/uploads/2019/05/ROTA-Brief2-ProductLandscape-SP-1-3.pdf
10382 EXD-12 Genital Herpes Cutaneous Herpes simplex virus double stranded DNA Live-attenuated Preclinical Excell Biotech 2018 USA 14 - 49 years NA NA NA Herpes simplex virus 2 glycoprotein D (gD-2) NA NA NA NA NA NA NA https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates NA
10384 RVx201 Genital Herpes Cutaneous Herpes simplex virus double stranded DNA Live-attenuated Preclinical Rational Vaccines Inc. 2021 UK NA NA NA NA HSV-2 infected cell protein NA NA NA NA NA NA NA https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates NA
10385 DeltaC-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose Subcutaneous NA Capsid deletion NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10386 Stop CHIKV SuperStop CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose Footpad injection NA NA NA NA NA NA NA 31921059 NA https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ NA
10387 DRDE-06 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA 3 doses NA NA NA Formalin inactivated produced in vero cells NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10391 Chimeric alphavirus Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins Recombinant alphavirus (EEEV, VEEV, SINV) with CHIKV structural proteins NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10392 CHIKV/IRES Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10393 VSV-CHIKV Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA Single dose NA NA CHIKV structural proteins NA NA NA NA NA NA NA https://academic.oup.com/jid/article/214/suppl_5/S488/2632628 NA
10399 LR-E2-E79 K Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA NA NA NA Clinical strain LR attenuated by mutations in heparin sulfate binding domains NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10400 CHIKV TM17-2 Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA NA NA NA Clinical strain attenuated by mutations in E2 transmembrane domain NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA
10401 CHIKV/IRES Chikungunya fever Exanthous Chikungunya virus positive-sense, single-stranded RNA Live-attenuated Preclinical NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA https://link.springer.com/chapter/10.1007/82_2019_175 NA